The role of myocardial BDNF signaling in myocardial physiology and myocardial response to pathological stress
心肌 BDNF 信号在心肌生理和心肌对病理应激反应中的作用
基本信息
- 批准号:9337496
- 负责人:
- 金额:$ 2.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistBiochemicalBioenergeticsBiogenesisBrainBrain-Derived Neurotrophic FactorCardiacCardiac MyocytesCause of DeathCreatine KinaseDataDeteriorationExerciseExercise PhysiologyGeneticGrowth FactorHealthcareHeartHeart failureHomeostasisHumanImpairmentMagnetic Resonance SpectroscopyMeasuresMediatingMitochondriaModelingMusMyocardialMyocardiumNamesNatural regenerationNeuronsPPAR gammaPathologicPathway interactionsPatientsPhosphocreatinePhosphotransferasesPhysiologicalPhysiologyPlayProductionProtein IsoformsPublic HealthPublicationsRelaxationReportingReservationsRespirationRespiratory physiologyRoleSignal TransductionSkeletal MuscleStressTestingTransgenic MiceTransgenic OrganismsTropomyosinUp-RegulationWorkbaseconstrictionendurance exerciseenhancing factorexercise capacityimage guidedimprovedin vivoindexingknock-downmouse modelneurogenesisneurotrophic factorneurotropinnew therapeutic targetnovelnovel therapeuticsoverexpressionpressurepreventprotective effectreceptorresponsesmall molecule
项目摘要
Project summary/Abstract
Brain-derived neurotrophic factor (BDNF) is a neurotrophin that regulates energy homeostasis,
mitochondrial bioenergetics and mediates exercise-induced neurogenesis in the brain. Both BDNF and its
receptor Tropomyosin related kinase receptor B (TrkB) are present in the myocardium. However, the role of
BDNF/TrkB signaling in myocardial physiology and the myocardial response to pathological stress is largely
unknown. My recent first author publication in PNAS found that constitutive myocardial BDNF/TrkB signaling is
required for normal cardiac contraction and relaxation. In new preliminary data, we found exercise induced BDNF
expression in the heart, whereas BDNF expression was decreased in myocardium from human heart failure
patients and mouse heart failure models. The mice with transgenic myocardial BDNF over-expression showed
preserved cardiac function against pressure overload induced by transaortic constriction (TAC). Conversely,
cardiac specific TrkB-/- mice (cTrkB-/-) displayed accelerated heart failure progression under pressure overload.
Moreover, a small molecule TrkB agonist prevented progression of heart failure in mice, suggesting the
BDNF/TrkB pathway could be a novel therapeutic target. Importantly, we found the expression of Peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), a master regulator of mitochondrial
biogenesis and mitochondrial respiratory function, was decreased in pressure overload in mice, while over-
expression of BDNF restored the impaired PGC1α expression in the stressed hearts. In addition, we also found
that the expression of myofibrillar isoform of creatine kinase (CK) was decreased in myocardium after TAC, and
recovered in cBDNF-tg mice. CK plays a critical role in energy reservation by ATP regeneration through
conversion of creatine phosphate (pCr) and ADP. Thus I will test the hypothesis that BDNF/TrkB activation is
critical for exercise physiology and protects against pathological stress by improving cardiac bio-energetics, via
PGC1α dependent mitochondrial function enhancement and CK mediated ATP regeneration. This hypothesis
will be addressed in three specific aims leveraging our novel transgenic mice models: 1) Determine the
importance of myocardial BDNF/TrkB on exercise capacity and exercise induced adaptive response; 2) Test
whether myocardial BDNF/TrkB signaling protects against pressure overload by activating PGC1α; 3) Test
whether myocardial BDNF/TrkB signaling protects against pressure overload by augmenting creatine kinase
mediated ATP regeneration
项目摘要/摘要
脑衍生的神经营养因子(BDNF)是一种神经营养蛋白,可调节能量稳态,
线粒体生物能学并介导运动诱导的大脑神经发生。 BDNF及其
心肌中存在与受体肌球蛋白相关激酶受体B(TRKB)。但是,
心肌生理中的BDNF/TRKB信号传导和对病理压力的心肌反应在很大程度上是
未知。我最近在PNAS中的第一篇作者出版物发现构成心肌BDNF/TRKB信号是
正常心脏收缩和放松所必需的。在新的初步数据中,我们发现运动诱导的BDNF
心脏的表达在心脏中的表达降低了BDNF的表达
患者和小鼠心力衰竭模型。显示了带有转基因心肌BDNF过表达的小鼠
防止心脏超负荷的心脏功能(TAC)引起的压力超负荷。反过来,
心脏特异性TRKB - / - 小鼠(CTRKB - / - )在压力超负荷下显示出心力衰竭进展。
此外,一个小的分子TRKB激动剂阻止了小鼠心力衰竭的进展,这表明
BDNF/TRKB途径可能是一个新型的热目标。重要的是,我们发现过氧化物酶体的表达
增殖者激活的受体伽马共振剂1-α(PGC1α),线粒体的主调节剂
在小鼠的压力超负荷中,生物发生和线粒体呼吸功能降低,而过度
BDNF的表达恢复了应力心脏中PGC1α的受损表达。此外,我们还发现
TAC后心肌的创造激酶(CK)的肌原纤维同工型的表达得到了改善,并且
在CBDNF-TG小鼠中恢复。 CK通过ATP再生在能源保留中起关键作用
创造磷酸盐(PCR)和ADP的转化。我将测试BDNF/TRKB激活的假设
运动生理至关重要,并通过改善心脏生物能源技术来防止病理压力
PGC1α依赖性线粒体功能增强和CK介导的ATP再生。这个假设
将在三个特定目标中解决我们的新型转基因小鼠模型:1)确定
心肌BDNF/TRKB对运动能力和运动引起的适应性反应的重要性; 2)测试
心肌BDNF/TRKB信号是否通过激活PGC1α来防止压力超负荷; 3)测试
心肌BDNF/TRKB信号是否通过增加创建激酶来防止压力超负荷
介导的ATP再生
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ning Feng其他文献
Ning Feng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ning Feng', 18)}}的其他基金
The role of transcription factor Ying-Yang 1 in the cardiac bioenergetics regulation
转录因子Ying-Yang 1在心脏生物能调节中的作用
- 批准号:
10688160 - 财政年份:2022
- 资助金额:
$ 2.53万 - 项目类别:
The role of transcription factor Ying-Yang 1 in the cardiac bioenergetics regulation
转录因子Ying-Yang 1在心脏生物能调节中的作用
- 批准号:
10504503 - 财政年份:2022
- 资助金额:
$ 2.53万 - 项目类别:
The Role of Myocardial BDNF signaling in Myocardial physiology and myocardial response to pathological stress
心肌 BDNF 信号在心肌生理和心肌对病理应激反应中的作用
- 批准号:
9620358 - 财政年份:2018
- 资助金额:
$ 2.53万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
- 批准号:82372196
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
The role of PPARγ in astrocyte pathobiology after exposure to repetitive mild traumatic brain injury
PPARγ 在重复性轻度脑外伤后星形胶质细胞病理学中的作用
- 批准号:
10739968 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Mrgprb2 mediated neuroinflammation after cerebral ischemia
Mrgprb2介导脑缺血后的神经炎症
- 批准号:
10644182 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Targeting GPR84 to Overcome Macrophage Mediated Resistance to Immunotherapy
靶向 GPR84 克服巨噬细胞介导的免疫治疗耐药性
- 批准号:
10660122 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别:
Evaluating the efficacy of a novel NASH therapeutic
评估新型 NASH 疗法的疗效
- 批准号:
10698971 - 财政年份:2023
- 资助金额:
$ 2.53万 - 项目类别: